200,000+ products from a single source!

sales@angenechem.com

Home > Pyridines > 5746-86-1

5746-86-1

5746-86-1 | 3-(2-Pyrrolidinyl)pyridine

CAS No: 5746-86-1 Catalog No: AG00IA8O MDL No:MFCD00016913

Product Description

Catalog Number:
AG00IA8O
Chemical Name:
3-(2-Pyrrolidinyl)pyridine
CAS Number:
5746-86-1
Molecular Formula:
C9H12N2
Molecular Weight:
148.2050
MDL Number:
MFCD00016913
IUPAC Name:
3-pyrrolidin-2-ylpyridine
InChI:
InChI=1S/C9H12N2/c1-3-8(7-10-5-1)9-4-2-6-11-9/h1,3,5,7,9,11H,2,4,6H2
InChI Key:
MYKUKUCHPMASKF-UHFFFAOYSA-N
SMILES:
C1CNC(C1)c1cccnc1

Properties

Complexity:
125  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
148.1g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
148.209g/mol
Monoisotopic Mass:
148.1g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
24.9A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
0.2  

Literature

Title Journal
Nornicotine and Nicotine Induced Neovascularization via Increased VEGF/PEDF Ratio. Ophthalmic research 20150101
Nornicotine application on cockroach dorsal unpaired median neurons induces two distinct ionic currents: implications of different nicotinic acetylcholine receptors. Neuroscience letters 20120614
Determination of nicotine exposure in dogs subjected to passive smoking using methanol extraction of hair followed by hydrophilic interaction chromatography in combination with Fourier transform mass spectrometry. Talanta 20120115
A one-year monitoring of nicotine use in sport: frontier between potential performance enhancement and addiction issues. Forensic science international 20111210
Validation of a liquid chromatography-tandem mass spectrometry method for the detection of nicotine biomarkers in hair and an evaluation of wash procedures for removal of environmental nicotine. Journal of analytical toxicology 20110701
Nicotine and metabolites in paired umbilical cord tissue and meconium specimens. Therapeutic drug monitoring 20110201
In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy. International journal of molecular sciences 20110101
Three nicotine demethylase genes mediate nornicotine biosynthesis in Nicotiana tabacum L.: functional characterization of the CYP82E10 gene. Phytochemistry 20101201
A novel pathway for nicotine degradation by Aspergillus oryzae 112822 isolated from tobacco leaves. Research in microbiology 20100901
Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine. Neuropharmacology 20100601
The analgesic and toxic effects of nornicotine enantiomers alone and in interaction with morphine in rodent models of acute and persistent pain. Pharmacology, biochemistry, and behavior 20100101
Quantitation of nicotine, its metabolites, and other related alkaloids in urine, serum, and plasma using LC-MS-MS. Methods in molecular biology (Clifton, N.J.) 20100101
The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. The international journal of neuropsychopharmacology 20091101
Drugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathology. Accounts of chemical research 20090519
Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation? Biochimica et biophysica acta 20090201
[Development of analytical method for determination nicotine metabolites in urine]. Przeglad lekarski 20090101
Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures. Clinical chemistry 20081201
Nicotine metabolism in pregnant and nonpregnant rabbits. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20080801
Enantiomeric analysis of anatabine, nornicotine and anabasine in commercial tobacco by multi-dimensional gas chromatography and mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080401
Quantification of nicotine, cotinine, trans-3'-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080215
Nornicotine-organocatalyzed aqueous reduction of alpha,beta-unsaturated aldehydes. Chemical communications (Cambridge, England) 20071214
Isolation and characterization of the cytochrome P450 gene CYP82E5v2 that mediates nicotine to nornicotine conversion in the green leaves of tobacco. Plant & cell physiology 20071101
Analyses of tobacco alkaloids by cation-selective exhaustive injection sweeping microemulsion electrokinetic chromatography. Journal of chromatography. A 20070914
Endogenous formation of N'-nitrosonornicotine in F344 rats in the presence of some antioxidants and grape seed extract. Journal of agricultural and food chemistry 20070822
Effects of tobacco and cigarette smoke extracts on serotonergic raphe neurons in the rat. Neuroreport 20070611
The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery. Journal of neurochemistry 20070401
Expression of the receptor of advanced glycation end products in the gingival tissue of smokers with generalized periodontal disease and after nornicotine induction in primary gingival epithelial cells. Journal of periodontology 20070401
Nornicotine inhibition of dopamine transporter function in striatum via nicotinic receptor activation. Synapse (New York, N.Y.) 20070301
Effects of nornicotine enantiomers on intravenous S(-)-nicotine self-administration and cardiovascular function in rats. Psychopharmacology 20070201
Genetic engineering of Nicotiana tabacum for reduced nornicotine content. Journal of agricultural and food chemistry 20061129
Re: Receptor for advanced glycation end product (RAGE) upregulation in human gingival fibroblasts incubated with nornicotine. Katz J, Caudle RM, Bhattacharyya I, Stewart CM, Cohen DM (2005;76:1171-1174). Journal of periodontology 20060201
CYP2A6 AND CYP2B6 are involved in nornicotine formation from nicotine in humans: interindividual differences in these contributions. Drug metabolism and disposition: the biological fate of chemicals 20051201
3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligands. Bioorganic & medicinal chemistry letters 20051001
Nicotine demethylation in Nicotiana cell suspension cultures: N'-formylnornicotine is not involved. Phytochemistry 20051001
A general procedure for the enantioselective synthesis of the minor tobacco alkaloids nornicotine, anabasine, and anatabine. The AAPS journal 20050901
Nicotine 5'-oxidation and methyl oxidation by P450 2A enzymes. Drug metabolism and disposition: the biological fate of chemicals 20050801
Receptor for advanced glycation end product (RAGE) upregulation in human gingival fibroblasts incubated with nornicotine. Journal of periodontology 20050701
Hammett correlation of nornicotine analogues in the aqueous aldol reaction: implications for green organocatalysis. The Journal of organic chemistry 20050429
6'-Methylpyrido[3,4-b]norhomotropane: synthesis and outstanding potency in relation to the alpha4beta2 nicotinic receptor pharmacophore model. Bioorganic & medicinal chemistry letters 20050215
Nornicotine aqueous aldol reactions: synthetic and theoretical investigations into the origins of catalysis. The Journal of organic chemistry 20041001
In vitro microsomal [correction of mircosomal] metabolism of N-benzyl and N-benzoylnornicotine derivates by rat. European journal of drug metabolism and pharmacokinetics 20040101
The nicotinic pharmacophore: thermodynamics of the hydrogen-bonding complexation of nicotine, nornicotine, and models. The Journal of organic chemistry 20031017
Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors. Bioorganic & medicinal chemistry letters 20030224
Long-lasting occupancy of central nicotinic acetylcholine receptors after smoking: a PET study in monkeys. Journal of neurochemistry 20030101
Locomotor stimulant effects of nornicotine: role of dopamine. Pharmacology, biochemistry, and behavior 20021201
Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20021201
Site of protonation of nicotine and nornicotine in the gas phase: pyridine or pyrrolidine nitrogen? Journal of the American Chemical Society 20020904
Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clinical chemistry 20020901
Aqueous aldol catalysis by a nicotine metabolite. Journal of the American Chemical Society 20020403
Contributory role for nornicotine in nicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices. Biochemical pharmacology 20011215
Nornicotine, a nicotine metabolite and tobacco alkaloid: desensitization of nicotinic receptor-stimulated dopamine release from rat striatum. European journal of pharmacology 20010928
A new and direct synthesis of 2-substituted pyrrolidines. The Journal of organic chemistry 20010907
In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation. Brain research 20010504
Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2'-(14)C]nicotine. Drug metabolism and disposition: the biological fate of chemicals 20010501
Enhancement of haloperidol-induced catalepsy by nicotine: an investigation of possible mechanisms. Canadian journal of physiology and pharmacology 20001101

© 2019 Angene International Limited. All rights Reserved.